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The trafficking of leukocytes from the blood to sites of inflamma-
tion is the cumulative result of receptor-ligand-mediated signaling
events associated with the leukocytes themselves as well as with
the underlying vascular endothelium. Our data show that Gi
signaling pathways in the vascular endothelium regulate a critical
step required for leukocyte diapedesis. In vivo studies using knock-
out mice demonstrated that a signaling event in a non-lymphohe-
matopoietic compartment of the lung prevented the recruitment of
proinflammatory leukocytes. Intravital microscopy showed that
blockade was at the capillary endothelial surface and ex vivo
studies of leukocyte trafficking demonstrated that a Gi-signaling
event in endothelial cells was required for transmigration. Collec-
tively, these data suggest that specific Gi2-mediated signaling
between endothelial cells and leukocytes is required for the ex-
travasation of leukocytes and for tissue-specific accumulation.
G proteins  inflammation  knockout mice  leukocyte trafficking 
pulmonary models
The tissue-specific recruitment of polymorphonucleated gran-ulocytes (i.e., neutrophils, basophils, and eosinophils) and
lymphocytes has been particularly well studied, including the
mechanisms mediating leukocyte tethering, rolling, adhesion,
and eventual transmigration from the circulation (1). These
studies have suggested that receptor–ligand interactions coupled
to Gi-containing heterotrimeric G proteins in leukocytes are
particularly important for the vectorial movement of leukocytes
to tissues in response to chemokine gradients (2). Thus, these
receptors represent potential drug targets for therapeutic ap-
proaches directed against inflammatory diseases (3).
The activation of Gi-coupled receptors leads to the dissoci-
ation of the heterotrimeric G protein and intracellular signaling
events mediated by the release of the Gi subunit (Gi) bound
to GTP and the free G dimer (4). The Gi family includes
genes encoding the subunits Gi1, Gi2, Gi3, Go, and Gz (5).
The activities of Gi family members, with the exception of Gz,
are distinguishable from other G subunits by their susceptibility
to pertussis toxin (PTX). The Gi1, Gi2, and Gi3 subunits are
expressed in many leukocytes and tissues involved in allergic
inflammation such as granulocytes (6), lymphocytes (7), airway
smooth muscle (8), airway epithelium (8), and endothelial cells
(9). Leukocytes that express these Gi family members appear
to express all three Gi subunits simultaneously. However,
studies assessing expression and function have suggested that
heterotrimeric complexes containing Gi2 and Gi3 are abun-
dant in leucocytes (2). Moreover, the importance of Gi-
mediated signaling events in leukocyte recruitment/accumula-
tion has been highlighted by using mouse models capitalizing on
the inhibitory character of PTX (6). However, the specific
mechanisms and, more importantly, the relevant cell types
involved in facilitating leukocyte accumulation remain largely
unknown.
Results and Discussion
Gi2-Signaling Pathways in a Resident Cell of the Lung Are Required
for the Accumulation of Eosinophils After Allergen Provocation. The
recruitment and accumulation of eosinophils in the airway
lumen and lung tissue after allergen provocation is a defining
feature found in both asthma patients (10) and animal models of
allergic respiratory inflammation (11). Gi-coupled CCR3 re-
ceptor–ligand interactions promoting chemotaxis are primarily
responsible for the allergen-induced accumulation of pulmonary
eosinophils (12). Gi2 and Gi3 transcripts dominate the mRNAs
encoding the PTX-sensitive Gi subunits of mouse peripheral
blood eosinophils (supporting information (SI) Fig. 5). We
therefore examined mice deficient in either Gi2 or Gi3 for
airway eosinophilia during asthma induced by sensitization and
aerosol challenge with ovalbumin (OVA). The accumulation of
eosinophils in the airway lumen of Gi2/mice was significantly
reduced relative to wild-type animals (Fig. 1A), but induced
eosinophilia in Gi3/ was unaffected (Fig. 1B). A similar
reduction in eosinophil accumulation was seen in the peribron-
chial areas of the lungs from Gi2/mice but not Gi3/ mice
relative to wild-type animals (SI Figs. 6 and 7). These data
indicate that Gi2-dependent signaling pathways are required for
eosinophil entry into tissues from the circulation.
In vitro chemotaxis assays demonstrated that the loss of Gi2
signaling in eosinophils did not prevent Gi-coupled receptor-
mediated chemotaxis (e.g., CCR3-mediated responses to
eotaxin-1/-2; ref. 12); instead, the loss of Gi2 may have even
enhanced the ability of the granulocytes to respond to chemoat-
tractant (Fig. 1C). Furthermore, these studies showed that the
eotaxin-CCR3-mediated chemotactic response of Gi2-deficient
eosinophils was abolished by PTX (Fig. 1D), demonstrating that
the signal transduction pathways mediating chemotaxis used the
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remaining Gi family members. These data support the hypoth-
esis that Gi signaling events modulate eosinophil responses to
available chemoattractants in vitro. However, the loss of aller-
gen-induced pulmonary eosinophilia in Gi2 knockout mice is
unlikely to be a consequence of an eosinophil-specific Gi2
deficiency but instead might depend on Gi2 in other cells or on
other signals.
Adoptive transfer of wild-type vs. Gi2/ eosinophils into
OVA-treated wild-type recipient mice was performed as an in
vivo approach to confirm our in vitro observation that the loss of
Gi2 in eosinophils appeared to enhance chemotactic responses
and therefore was not directly responsible for the lack of
eosinophil accumulation observed in the lungs of OVA-treated
Gi2/ mice. IL-5 transgenic mice (NJ.1638; ref. 13) or com-
pound Gi2-deficient IL-5 transgenic animals (Gi2//NJ.1638)
were used to isolate pure (98.5%) populations of wild-type and
Gi2/ peripheral blood eosinophils, respectively. Adoptive
transfer was achieved by the repeated i.p. instillation of eosin-
ophils into sensitized wild-type mice during the challenge phase
of the OVA protocol. In some studies, the eosinophils were
labeled ex vivo with the fluorescent tag carboxyfluorescein
diacetate-succinimidyl ester (CFDA-SE; Molecular Probes Inc.,
Eugene, OR) to confirm the identity of the eosinophils in the
lung as being derived from those adoptively transferred (SI Fig.
8). Assessment of airway cell populations after adoptive transfer
of wild-type eosinophils demonstrated that their increased avail-
ability in circulation resulted in a greater number of airway
eosinophils (Fig. 2A). However, the adoptive transfer of the same
number of Gi2/ eosinophils into OVA-treated wild-type
animals resulted in an elevated OVA-induced airway eosino-
philia that was even greater than the increase observed after
transfer of wild-type eosinophils (Fig. 2A). This pattern also
extended to lung tissue where transfer of Gi2/ eosinophils
resulted in higher levels of accumulation compared with transfer
of wild-type eosinophils (Fig. 2A and SI Fig. 9). These transfer
studies collectively confirmed our in vitro transwell chemotaxis
results and showed that Gi2/ eosinophils are capable of
responding to chemotactic gradients and, if anything, may have
a greater inherent ability for migration relative to wild-type
eosinophils. Interestingly, the reciprocal transfer of wild-type
eosinophils into OVA-treated Gi2/ mice did not result in a
pulmonary eosinophilia. Thus, allergen-induced recruitment of
eosinophils in this model was absolutely dependent on the
presence of a Gi2 signaling pathway in the recipient mice,
regardless of the Gi2/ status of the eosinophils (Fig. 2A).
The widespread expression of Gi2 among all leukocytes, includ-
ing cells necessary for acquired immune responses (e.g., dendritic
cells, B cells, and T lymphocytes; ref .4), suggested the possibility
that the observed decrease in eosinophil accumulation in the lungs
of OVA-treated Gi2/ mice was simply a consequence of signal-
ing defects limiting immune responses with a consequent loss of
eosinophilia. To test this hypothesis, we examined asthma-induced
eosinophilia in bone marrow reconstituted mice in which all he-
matopoietic, but not the other host cell, lacked Gi2. OVA sensi-
tization and challenge of mice reconstituted with wild-type cells
revealed bronchoalveolar lavage (BAL) eosinophilia comparable to
normal mice. In contrast the eosinophilic response in mice recon-
stituted with Gi2/ bone marrow was nearly 3-fold greater. Thus
the requirement for Gi2 in asthma-induced eosinophilia is not
dependent on lymphohematopoietic cells. In accord with this
finding, the immune response itself during OVA-induced asthma
was not reduced in Gi2/mice, as assessed by production of IL-4,
IL-5, or IFN- (Fig. 2C). Moreover, OVA treatment of irradiated
wild-type recipients after engraftment of wild-type vs. Gi2/ bone
marrow also displayed equivalent BAL cytokine levels, demon-
strating that the Gi2-dependent differences in pulmonary eosin-
ophil accumulation were not the result of compromised OVA-
induced immune responses (Fig. 2C). Attempts to do the reciprocal
Fig. 1. Allergen-induced eosinophil accumulation uniquely relies on Gi2
signaling mechanisms that are independent of cell autonomous events in
eosinophils. OVA-induced eosinophil accumulation in the airway lumen of
Gi2/ (A), but not Gi3/ (B), mice was significantly lower (*, P  0.05)
relative to wild-type animals (n  8 mice per group). (C) Eosinophil
transwell chemotaxis assays demonstrated that in the absence of Gi2
signaling events, in vitro eosinophil migration to recombinant mouse
eotaxin-1 was the same, if not nominally higher, relative to wild type. (D)
PTX pretreatment of eosinophils before the transwell chemotaxis assay
showed that the blockade of all Gi-signaling events abolished eotaxin-1-
induced chemotaxis, thus demonstrating that the CCR3 receptor-mediated
eosinophil chemotaxis occurring in the absence of Gi2 results exclusively
from signaling events using the remaining PTX-sensitive G subunits, Gi1
and/or Gi3.
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engraftment of wild-type marrow into Gi2/ recipient mice have
been unsuccessful (i.e., the mice die of an apparent septicemia
within 5–7 days of engraftment), suggesting that Gi2 signaling
events in the non-lymphohematopoietic tissues of these knockout
recipients may be necessary for the recruitment and incorporation
of stem cells in the marrow compartments of these mice.
Our studies involving the transfer of eosinophils indicated that
the lack of pulmonary eosinophils during asthma in Gi2/ mice
was not due to a lack of production of eosinophils. Furthermore,
assessments of eosinophilopoiesis in the bone marrow of Gi2/
animals showed no effect on the production of circulating eosino-
phils in allergen naı¨ve and allergen sensitized/aerosol-challenged
mice (data not shown). However, leukocyte counts and cell differ-
entials did show that eosinophils ‘‘backed-up’’ in the peripheral
blood of Gi2/ mice, accumulating to higher levels in the periph-
eral blood of both allergen naı¨ve and OVA-treated animals (Fig.
3A). Moreover, and in agreement with published observations (14),
this increased accumulation extended equally to all white blood
cells, each differentially accumulating to higher levels in Gi2/
mice relative to wild-type control groups (Fig. 3A).
Endotoxin-Mediated Pulmonary Accumulation of Neutrophils also
Occurs as a Function of a Gi2-Signaling Pathways in a Resident Cell
of the Lung. To extend our studies on the role of Gi2 in leukocyte
migration to the lungs, we next assessed the recruitment and
tissue accumulation of neutrophils as a function of an innate
response to endotoxin; a model system that has been exploited
in pulmonary studies by intranasal administration of LPS (see,
for example, ref. 15). As with eosinophils, neutrophils have been
previously characterized as expressing both Gi2 and Gi3
subunits (16), but the accumulation of these leukocytes in the
lung after LPS administration was different in Gi2 vs. Gi3
knockout mice. The loss of Gi2 nearly abolished the LPS-
induced pulmonary neutrophilia (Fig. 3B), whereas the neutro-
philia induced in Gi3-deficient mice was unaffected relative to
wild-type animals (Fig. 3B). Despite the loss of LPS-induced
neutrophil accumulation in the lungs of Gi2/ mice, this
phenomenon did not appear to be a consequence of reduced
chemotaxis resulting from the Gi2 deficiency in the neutrophil
itself. In vitro assessments of chemotaxis by using transwell assays
(Fig. 3C) demonstrated that Gi2-deficient neutrophils were
capable of migrating in response to a ligand for the Gi-coupled
receptor CXCR2 (MIP-2; ref. 17). Interestingly, in vitro MIP-2-
mediated chemotaxis of Gi2-deficient neutrophils appeared to
be enhanced relative to wild-type controls, consistent with our
observations of eosinophils and previous studies by others
investigating leukocytes deficient in genes mediating G protein-
coupled receptor signal transduction (18). The similarity of the
data examining both neutrophil and eosinophil recruitment
again supports the leukocyte-independent character of the Gi2
deficiency in knockout mice. Further, the accumulation of
leukocytes in the blood suggests a deficiency at an early stage in
Fig. 2. Gi2 signaling in a non-lymphohematopoietic compartment(s) in the lung is necessary for eosinophil accumulation after allergen provocation. (A)
Adoptive transfer of eosinophils into OVA-treated wild-type recipients (n8–10 mice per group) demonstrated that Gi2/eosinophils have an increased ability
to traffic to both the airway lumen and the peribronchial areas of the lung. In contrast, the reciprocal transfer of wild-type eosinophils into OVA-treated Gi2/
recipients demonstrated that eosinophil accumulation depended on lung-associated Gi2 signaling. A, transfer of PBS vehicle alone. *, P 0.05; †, significantly
different (P 0.05) from all other OVA groups examined. (B) Bone marrow engraftment of wild type recipients (Donor Marrow) demonstrated that the lack of
eosinophil recruitment to the lung observed in Gi2/ mice (Non-Irradiated) was a consequence of a Gi2 signaling event(s) in a lung structural cell type(s); n
10–12 mice per group, *, P 0.05. (C) OVA-induced pulmonary Th2 cytokines and IFN- levels in Gi2/ mice are unaffected relative to OVA-treated wild type
(Non-Irradiated). Moreover, OVA-induced Th2 cytokine and IFN- levels in OVA-treated mice after engraftment of Gi2 marrow into wild-type recipients was
also unaffected relative to OVA-treated wild-type controls (Donor Marrow). All values presented are means  SEM (n  8 mice per group).








cell exodus from the circulation. Once out of the vasculature, the
leukocytes appear to have the ability to traffic along chemo-
attractant gradients and accumulate within specific tissue
compartments.
Leukocyte Diapedesis and, in Turn, Tissue Accumulation Occurs as a
Function of a Gi2-Signaling Event(s) in Endothelial Cells.Because our
results suggested a leukocyte-independent impairment early in
leukocyte trafficking from the blood, we next used intravital
microscopy to examine endothelial cell–leukocyte interactions
to determine whether a Gi2 deficiency in endothelial cells alters
interactions with leukocytes in such a way as to limit extravasa-
tion. Visualization of abdominal mesenteric postcapillary
venules from wild-type and Gi2/ mice (Fig. 4A and SI Movie
1) after systemic i.p. administration of LPS [10 g in 100 l of
phosphate-buffered saline (PBS)] demonstrated enhanced ac-
cumulation of stationary leukocytes on the endothelial surfaces
in Gi2/ animals relative to wild-type mice. Specifically,
quantitative assessments of the leukocytes adhering to the
venules demonstrated that whereas LPS exposure of wild-type
mesentery induced only a nominal increase in static adherence
to the underlying endothelium, the loss of Gi2 led to a 7-fold
increase in the number of immobilized leukocytes (Fig. 4A and
SI Fig. 10). This greater number of stationary leukocytes in
knockout mice could be a consequence of enhanced cell adhe-
sion mediated by the absence of a Gi2-signaling event(s) in the
endothelium. Alternatively, the loss of Gi2 in the endothelium
of knockout mice may slow down or block diapedesis, increasing
the steady-state number of static endothelial-bound leukocytes
which ‘‘back-up’’ on the endothelial surface. Our observation
that all leukocyte subtypes accumulate in the blood of Gi2/
mice, together with data demonstrating that different leukocyte
subtypes use diverse repertoires of receptor–ligand interactions
to mediate adhesion, suggest that a Gi2-dependent effect on cell
adhesion is unlikely. This conclusion was confirmed by using ex
vivo laminar flow assays to assess lymphocyte adherence and
migration through an endothelial cell monolayer (Fig. 4 B and
C). In these studies, Gi-signaling events were abolished in the
endothelial cell monolayer by pretreatment with PTX. This
pretreatment of the endothelial cells had no effect on cytotox-
icity/viability or surface expression levels of the vascular cell
adhesion molecule 1 (VCAM-1) (SI Figs. 11 and 12, respec-
tively). The laminar flow study showed that 4-integrin/VCAM-
1-dependent firm adhesion of lymphocytes was unaffected in the
absence of endothelial cell Gi signaling (Fig. 4B), suggesting
that effects on adhesion mediated by endothelial Gi2 signaling
were not responsible for the blockade of leukocyte recruitment
in knockout mice. However, the subsequent migration of firmly
adherent lymphocytes through the endothelial cell monolayer
(i.e., transmigration) in the laminar flow assay showed that this
process was significantly inhibited after PTX treatment (i.e., a
Gi-dependent event) of the monolayer (Fig. 4C). This result
suggests that a signaling event(s) in the venule endothelium of
Gi2/mice specifically is required for efficient transmigration/
diapedesis.
Activated leukocyte trafficking and, in particular, the speci-
ficity involved in the extravasation cascade, requires a complex
exchange of signals (‘‘handshakes’’) between the mobile acti-
vated leukocytes and underlying vascular endothelial cells. The
general responses of leukocytes and endothelial cells to chemo-
kines have been studied (19) as has the role of adhesion
molecules and their receptors in the trafficking response (20).
The involvement of Gi-coupled receptors in leukocyte activa-
tion, rolling, and subsequent arrest at the endothelial surface
before diapedesis has been shown to involve a PTX-sensitive step
at the level of the leukocyte (e.g., Gi-coupled chemokine-
mediated recruitment). However, our data also suggest that the
complex interaction between endothelial cells and leukocytes
responding to inflammatory signals includes a signal transduc-
tion event involving the Gi2 isoform in endothelial cells, which
leads to the extravasation of circulating leukocytes. The activa-
tion of this pathway may occur in several different ways. For
example, the interaction of endothelial cells with leukocytes
activates a variety of ectoenzymes. Thus, transmigration may
require a Gi2-mediated response in the endothelial cells to
signals or ligands generated by these ectoenzymes (reviewed in
ref. 21). Alternatively, local changes in nitric oxide have been
shown to modify the levels of RGS (Regulators of G protein
Signaling) proteins that are required for regulating Gi2-
signaling events in endothelial cells (22). Moreover, ‘‘outside-in’’
Fig. 3. The loss of Gi2 signaling in knockout mice leads to nonspecific
increases in all circulating white blood cell types and severely limits LPS-
induced airway neutrophil accumulation. (A) Increase in all white blood cell
types is observed in both allergen-naı¨ve and OVA-treated Gi2/ mice. The
data presented represent means SEM (n 5 mice per group). *, significantly
different (P 0.05) from wild-type saline control mice. †, significantly differ-
ent (P  0.05) from OVA-treated wild-type mice. (B) LPS administered to
Gi2/ or Gi3/ mice (n 7–10 mice per group; wild-type animals served as
negative controls) showed that the induced BAL neutrophil levels 16 h after
administration were significantly decreased in Gi2/mice but unaffected in
Gi3/ animals. *, P  0.05. (C) Transwell chemotaxis assays demonstrated
that in the absence of Gi2 signaling events, in vitro neutrophil migration to
MIP-2 was not lower but instead nominally higher relative to wild type.
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Gi2-mediated signaling events in endothelial cells leading to the
release and movement of previously stationary leukocytes may
occur through the mobilization and activation of intercellular
adhesion molecule/VCAM-tetraspanin adhesion complexes (23)
or the regulation of endothelial integrity through Pky2-mediated
affects on vascular endothelial-cadherin adhesion (24). Regard-
less of the specific mechanism(s) mediating tissue accumulation
of leukocytes, our data have surprisingly shown that a Gi2/-
dependent endothelial cell signaling event(s) is required for
efficient diapedesis. Equally surprising was the fact that the
overlapping functions of other Gi family members that are
generally capable of compensating for the loss of Gi2 in
leukocytes are not able to do so in the endothelial cells.
These observations have clinical implications and may offer
new possibilities for the treatment of inflammatory diseases. In
particular, the observation that an endothelial cell-specific signal
transduction event(s) is required for the extravasation of mul-
tiple proinflammatory leukocyte subtypes suggests that this
could be a rate-limiting step regulating their tissue accumulation
in a myriad of diseases. Moreover, the events leading to diape-
desis may be the result of a number of endothelial cell receptors
that are coupled only to Gi2-containing G proteins. Therefore,
these receptors may potentially represent targets for drug inter-
vention that are potentially applicable to a wide variety of both
chronic and acute inflammatory diseases.
Materials and Methods
Mice. Gi2 and Gi3-null mice were generated by homologous
recombination in embryonic stem cells (background strain: 129)
as described (25). Subsequent generations of G protein-deficient
animals were the result of backcrosses (F5) onto the inbred
strain C57BL/6J, a strain that does not display the baseline
inflammatory responses observed in the original 129 knockout
animals (25). Eosinophils were isolated from Gi2/ or Gi3/
mice constitutively expressing mouse IL-5 that resulted from
crosses of the respective G protein-deficient animals with the
IL-5 transgenic line NJ.1638 [C57BL/6J (20 backcross gener-
ations)] (13).
Induction of Allergic Airway Inflammation. The OVA model of
allergic pulmonary inflammation has been described (26). For
details see SI Materials and Methods.
LPS-Induced Airway Inflammation. Mice were lightly anesthetized
with isoflurane before intranasal administration of 10 g (20 l
total volume) of LPS (Sigma, St. Louis, MO). The number of
neutrophils recruited to the airways 16 h post-LPS administra-
tion were determined by BAL, modifying a described protocol
(27). BAL fluid was recovered following instillation of saline
supplemented with 2% FCS (1 ml). The BAL fluid was centri-
fuged at low speed (10 min at 400 g; 4°C). The recovered cells
were counted by using a hemocytometer, and cell differentials
were performed on stained cytospin preparations (Diff-Quik;
Dade Behring, Newark, DE) counting 300 cells.
Lung Histology and Immunohistochemistry. Lung tissue for histo-
logical analysis was obtained by instilling 1 ml of 10% neutral-
buffered formalin (30 cm H2O constant pressure) through a
cannula inserted into the trachea. The excised lung was im-
mersed in formalin for 24 h (at 4°C). Parasagittal sections (4 m)
were obtained from paraffin-embedded tissue, stained with
hematoxylin and eosin, and analyzed by bright field microscopy.
Eosinophil recruitment to lung tissue compartments was deter-
mined by immunohistochemistry using a rabbit polyclonal anti-
mouse major basic protein (MBP) antisera (28). Eosinophils
surrounding the airways were quantified by counting the number
of MBP-positive cells per square millimeter of submucosal tissue
surrounding the bronchioles.
Fig. 4. The loss of Gi2 signaling in the vascular endothelium leads to the
accumulation of immobilized cells in postcapillary venules through a block-
ade of diapedesis. (A) Intravital photomicroscopy of LPS-exposed mesen-
tery postcapillary venules showed that the loss of Gi2 resulted in a
significant increase of stationary leukocytes adherent to the vascular en-
dothelium. Numbered white arrows indicate individual rolling leukocytes
and black arrows identify stationary leukocytes. The Gi-dependence of
lymphocyte binding and migration through an endothelial cell monolayer
was assessed by using an ex vivo parallel plate flow chamber under
conditions of laminar flow comparable to pressures observed in postcap-
illary venules [i.e., 2 dynes (1 dyne  10 N)/cm2]. (B) VCAM-1-dependent
firm adhesion was blocked by antibodies against either endothelial
VCAM-1 or lymphocyte associated 4-integrin but was unaffected by PTX
pretreatment of the endothelial cell monolayer. *, significantly different
(P  0.05) from no-antibody control group. (C) Lymphocyte migration
through an endothelial cell monolayer is blocked in a concentration-
dependent fashion by pretreatment of the endothelial cells with PTX. ‘‘No
treatment,’’ endothelial cells treated with PBS. *, significantly different
(P  0.05) from PBS-treated control group.








Isolation of Mouse Eosinophils, Isolation of Splenocytes, and In Vitro
Assessment of Leukocyte Chemotaxis. For details, see SI Materials
and Methods.
Eosinophil Adoptive Transfer and Ex Vivo Labeling of Eosinophils and
Monitoring the Recruitment/Accumulation of Labeled Eosinophils
Following Adoptive Transfer to the Peritoneal Cavity. For details,
see SI Materials and Methods.
Hematopoietic Engraftment by Bone Marrow Transfer. Exposing
female wild-type mice to 1,100-cGy whole body lethal irradiation
generated complete bone marrow chimeras. Within 3 h of
irradiation, 1 107 bone marrow cells from wild-type or Gi2/
male donors were transferred by tail vein injection. Engrafted
mice were used in experiments after a45-day recovery period.
Recovered mice were sensitized and aerosol challenged with
OVA (saline for controls) by using the protocol noted above, and
BAL eosinophils were enumerated 24 h after the last challenge.
Eosinophils comprise 1% of leukocytes in the airways of
saline-challenged mice of any group. Donor cell engraftment of
90% was achieved in all recipients as determined by a PCR
assay designed to quantify X vs. Y chromosome-specific se-
quences (29).
Cytokine Assays. Cytokine levels in BAL fluid were determined
by ELISA. Mouse IL-4, IL-5, IFN-, and IL-12 ELISA kits
(R&D Systems, Minneapolis, MN) were used according to the
manufacturer’s protocol. The limits of detection for each assay
were as follows: IFN-  30 pg/ml, IL-4  10 pg/ml, IL-5  10
pg/ml, and IL-12  10 pg/ml.
In Vivo Assessment of Leukocyte Intracapillary Rolling and/or Adhe-
sion in Postcapillary Venules by Intravital Microscopy and Ex Vivo
Assessments of Lymphocyte Adhesion and Migration. For details,
see SI Materials and Methods.
Determination of VCAM-1 Endothelial Cell Expression Using Flow
Cytometry. mHEVa endothelial cell monolayers (before or after
exposure to PTX) were disassociated into single-cell suspensions
by using 0.3% EDTA, and the recovered cells were washed in
RPMI-1640 containing 20% FCS. Cells were stained in PBS/
0.5% BSA/0.15% NaN3 with rat anti-mouse VCAM-1 antibody
(normal rat IgG was used as a negative control for primary
antibody staining) and visualized with biotin-conjugated goat
anti-rat antibodies and strepavidin-phycoerythrin. Analysis was
performed on a FACScan flow cytometer (BD Biosciences, Palo
Alto, CA) with CellQuest Pro software (BD Biosciences).
Statistical Analysis. All data presented are the means  standard
errors (SEM). Statistical analysis was performed on parametric
data by using t tests with differences between means considered
significant when P  0.05.
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